partners
Partnering to Revolutionize Drug Development
Pathos collaborates with leading pharmaceutical and biotech organizations to accelerate the development of oncology therapies. Our multimodal data and proprietary AI model identify patient populations most likely to respond — improving trial design, optimizing resources, and driving higher success rates.
partners
Partnering to Revolutionize Drug Development
At Pathos, our mission begins and ends with patients. Every dataset we analyze, every model we refine, and every discovery we make is guided by one purpose — to bring more precise, more effective treatments to the people who need them most.
Collaboration Across Every Stage of Development
Pathos partners with organizations across the full spectrum of drug discovery and clinical development. Our AI technology enables data-driven insights, adaptive trial design, and accelerated timelines for novel therapies.
In-Licensing Opportunities
Access opportunities at various stages of development — from early discovery through late-stage clinical programs — with global or regional focus.
Collaborative Opportunities
Partner with Pathos to co-develop or optimize therapeutic assets through patient selection, trial simulation, or multimodal data analysis.
Innovative Programs
We welcome creative partnerships that leverage our AI and patient insight models to enhance therapeutic combinations, reposition assets, or uncover new indications.
Built for Smarter Science and Faster Success
Pathos integrates multimodal oncology data — genomics, imaging, outcomes, and clinical trial histories — at unprecedented scale. Our proprietary AI model simulates thousands of trial scenarios, reduces uncertainty, and improves clinical predictability.
By combining real-world data with advanced AI models, Pathos helps therapies reach the right patients faster.
Investing in the Future of Biopharma
Pathos is building a repeatable, data-driven model for drug development — one that scales insight, accelerates valiadation, and compounds value across every program.
For investment and partnership inquiries, reach out to learn more about how we’re redefining the economics of oncology innovation.
Innovation stalls
Therapies that could work — if tested in the right subgroups – never reach patients.
Capital is Lost
Investors shoulder enormous risk with little predictability.
Patients are left behind
Those who don’t respond to traditional therapies are left without options.
Built for Smarter Science and Faster Success
Pathos integrates multimodal oncology data — genomics, imaging, outcomes, and clinical trial histories — at unprecedented scale. Our proprietary AI model simulates thousands of trial scenarios, reduces uncertainty, and improves clinical predictability.
By combining real-world data with advanced AI models, Pathos helps therapies reach the right patients faster.
Innovation stalls
Therapies that could work — if tested in the right subgroups – never reach patients.
Capital is Lost
Investors shoulder enormous risk with little predictability.
Patients are left behind
Those who don’t respond to traditional therapies are left without options.
Investing in the Future of Biopharma
Pathos is building a repeatable, data-driven model for drug development — one that scales insight, accelerates valiadation, and compounds value across every program.
For investment and partnership inquiries, reach out to learn more about how we’re redefining the economics of oncology innovation.
The Future of Biopharma Starts With Pathos.
Together, we can bring precision medicines to patients faster — with greater confidence, efficiency, and impact.
